Drug Profile
Gonadotropin releasing hormone transdermal patch - Vyteris
Alternative Names: Fertility hormone peptide Smart Patch™ transdermal patch; GnRH transdermal patch - VyterisLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Vyteris
- Class Gonadotropins; Hormones; Infertility therapies; Oligopeptides
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Female infertility
Most Recent Events
- 06 Jun 2013 Vyteris plans to sell transdermal drug delivery patents, subject to approval of US Bankruptcy Court
- 06 Jun 2013 No development reported - Phase-II for Female infertility in USA (Transdermal)
- 10 Nov 2010 Vyteris receives a grant under the US Government's Qualifying Therapeutics Discovery Project for the development of Smart Patch-based therapeutics in female infertility and diabetes